Ntawv Thov Nyiaj Rov Qab thiab Kev Thov Kom Rov Txiav Txim Dua
Prescription Drug Claim Form
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3571 - 3580 ntawm 3669
Kev Noj Qab Nyob Zoo thiab Kev Noj Qab Haus Huv
2025 Preventive Care Recommendations
Tus kws kho mob
QP54-25 “Serious Illness Conversations: Improving Patient Care at End of Life” Training Available July/August 2025
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 25, 2025
Tus kws kho mob
Recent FDA-Approved Medical Drugs or Medical Drug Indications Evaluation Process List
Tus kws kho mob
QP53-25 Update for New-to-Market Medical Drugs: nipocalimab-aahu
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 25, 2025
Tus kws kho mob
Filspari (sparsentan) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2025
Tus kws kho mob
Filspari (sparsentan) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2025
Tus kws kho mob
Factor VIII and von Willebrand Factor - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2025